HOME
ABOUT US
STRATEGY
TEAM
PORTFOLIO
4BATLE ICAV
NEWSROOM
CONTACT
More
4BIO Capital raises $50 million in first close of new advanced therapies fund
Spark Therapeutics enters into definitive merger agreement with Roche
4BIO portfolio company Orchard Therapeutics announces ADA-SCID follow-on results
EGLSF I wins two EuroHedge Emerging Fund Management Awards
4BIO portfolio company Orchard Therapeutics goes public
4BIO portfolio company Orchard Therapeutics Announces $150 Million Series C Financing